BMI View: Medicine pricing controls will continue to limit the growth potential of the Philippine
pharmaceutical market. However, over the longer term progressive implementation of universal healthcare
coverage, coupled with the country’s relatively strong economic growth and political stability, will boost
pharmaceutical consumption.
Headline Expenditure Projections
? Pharmaceuticals: PHP138.45bn (USD3.20bn) in 2013, rising to PHP143.55bn (USD3.26bn) in 2014;
+3.7% in local currency terms and +1.8% in US dollar terms.
? Healthcare: PHP545.09bn (USD12.62bn) in 2013, rising to PHP611.29bn (USD13.89bn) in 2014;
+12.1% in local currency terms and +10.1% in US dollar terms.

Table Of Contents

BMI Industry View 7
SWOT 9
Political 11
Economic 12
Business Environment 13
Industry Forecast 14
Pharmaceutical Market Forecast 14
Table: Pharmaceutical Sales, Historical Data And Forecasts (Philippines 2010-2018) 16
Healthcare Market Forecast 17
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Philippines 2010-2018) 18
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Philippines 2010-2018) 19
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Philippines 2010-2018) 19
Prescription Drug Market Forecast 20
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Philippines 2010-2018) 21
Patented Drug Market Forecast 22
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Philippines 2010-2018) 23
Generic Drug Market Forecast 24
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Philippines 2010-2018) 26
OTC Medicine Market Forecast 27
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Philippines 2010-2018) 28
Pharmaceutical Trade Forecast 29
Table: Pharmaceutical Trade Data And Forecasts (Philippines 2012-2018) 32
Table: Pharmaceutical Trade Data And Forecasts local currency (Philippines 2012-2018) 32
Other Healthcare Data 33
Key Risks To BMI's Forecast Scenario 34
Macroeconomic Forecasts 35
Economic Analysis 35
Investment To Continue Its Charge 35
Likely Recovery In The Export Sector 37
Typhoon Yolanda To Spur Public Spending 38
Remittances Supporting Private Consumption Growth 38
Risks To Economic Outlook 39
Table: Philippines - Economic Activity 40
Industry Risk Reward Ratings 41
Asia Risk/Reward Ratings 41
Philippines Risk/Reward Ratings 47
Rewards 47
Risks 47
Market Overview 49
Industry Trends And Developments 50
Epidemiology 50
Healthcare Sector 54
Health Insurance 58
Healthcare Sector Financing 61
Medical Tourism 61
Biotechnology And Research 62
Traditional Medicines 64
Clinical Trials 65
Regulatory Development 66
Table: History Of Food And Drugs Administration 67
Intellectual Property Regime 70
Pricing Regime 75
Table: Medicines Subject To March 31 2010 Government Mediated Access Price 79
Reimbursement Regime 80
International Cooperation 81
Competitive Landscape 84
Pharmaceutical Industry 84
Table: Pharmaceutical Industry Overview 84
Domestic Pharmaceutical Industry 84
Pharmaceutical Distribution and Retail 87
Table: Overview Of BnB, BNB and P100 Programme 92
Table: Cost Of Generic Drugs In Philippines (PHP) 92
Table: Number Of BnBs And BNBs In Selected Philippine Regions 93
Company Profile 94
Unilab 94
Pascual Laboratories 97
Pacific Pharmaceutical Generics 100
MediChem Pharmaceuticals 102
GlaxoSmithKline Philippines 104
Pfizer 107
Novartis 111
Merck & Co 116
Sanofi 118
Demographic Forecast 122
Demographic Outlook 122
Table: The Philippines' Population By Age Group, 1990-2020 ('000) 123
Table: The Philippines' Population By Age Group, 1990-2020 (% of total) 124
Table: The Philippines' Key Population Ratios, 1990-2020 125
Table: The Philippines' Rural And Urban Population, 1990-2020 125
Glossary 126
Methodology 128
Pharmaceutical Expenditure Forecast Model 128
Healthcare Expenditure Forecast Model 128
Notes On Methodology 129
Risk/Reward Ratings Methodology 130
Ratings Overview 131
Table: Pharmaceutical Risk/Reward Ratings Indicators 131
Indicator Weightings 132

List Of Tables

Table: Pharmaceutical Sales, Historical Data And Forecasts (Philippines 2010-2018)
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Philippines 2010-2018)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Philippines 2010-2018)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Philippines 2010-2018)
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Philippines 2010-2018)
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Philippines 2010-2018)
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Philippines 2010-2018)
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Philippines 2010-2018)
Table: Pharmaceutical Trade Data And Forecasts (Philippines 2012-2018)
Table: Pharmaceutical Trade Data And Forecasts local currency (Philippines 2012-2018)
Table: Philippines - Economic Activity
Table: History Of Food And Drugs Administration
Table: Medicines Subject To March 31 2010 Government Mediated Access Price
Table: Pharmaceutical Industry Overview
Table: Overview Of BnB, BNB and P100 Programme
Table: Cost Of Generic Drugs In Philippines (PHP)
Table: Number Of BnBs And BNBs In Selected Philippine Regions
Table: The Philippines' Population By Age Group, 1990-2020 ('000)
Table: The Philippines' Population By Age Group, 1990-2020 (% of total)
Table: The Philippines' Key Population Ratios, 1990-2020
Table: The Philippines' Rural And Urban Population, 1990-2020
Table: Pharmaceutical Risk/Reward Ratings Indicators